wins contract

Entegrion Awarded $9.84 Million

Entegrion Awarded $9.84 Million Contract Extension Research Triangle Park, NC, August 25, 2011 – The U.S. Navy has awarded Entegrion, the life sciences development company focused on expanding the therapeutic potential of the human vascular system, an extension of up to $9.84 million on an existing contract to develop a multi-functional resuscitation fluid. The Navy’s…

Read More

Entegrion Awarded $43.7 Million

Entegrion Awarded $43.7 Million to Bring Resusix™ to Market. Research Triangle Park, NC, October 4, 2011 – Entegrion announced today it has received a contract valued up to $43.7 Million from the Department of Defense. The RTP life sciences development company will apply the funding to the clinical development of Resusix™, its proprietary dehydrated pathogen-inactivated…

Read More